Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_assertion type Assertion NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_head.
- NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_assertion description "[Moreover, we could prove disease progression on a cellular level months before the clinical onset of sAML after a period of MDS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_provenance.
- NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_assertion evidence source_evidence_literature NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_provenance.
- NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_assertion SIO_000772 11860441 NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_provenance.
- NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_assertion wasDerivedFrom befree-20140225 NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_provenance.
- NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_assertion wasGeneratedBy ECO_0000203 NP501192.RAwu9N_FUHQinO2eJ76Rwk7l1ZCBQVb2UkmtFgl-_1OaE130_provenance.